Tuesday, November 20, 2007
Early Communication About and Ongoing Safety Review: Varenicline (marketed as Chantix)
This was posted on the FDA site today. Early Communication About and Ongoing Safety Review: Varenicline (marketed as Chantix)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment